Holen Sie sich die Stockscreener-App
1.16
0.37%
0.0043
Handel nachbörslich:
1.17
0.01
+0.86%
Zenvia Inc Aktie (ZENV) Neueste Nachrichten
Zenvia Inc(ZENV) Price Target Increased by 5.68% to 1.58 - MSN
Zenvia Inc (ZENV) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Revenues Working Against Zenvia Inc.'s (NASDAQ:ZENV) Share Price Following 26% Dive - Simply Wall St
Zenvia Inc. (NASDAQ:ZENV) Short Interest Update - MarketBeat
ZENVIA sets agenda for fiscal third quarter and first nine months 2024 results - StockTitan
This Zenvia Insider Increased Their Holding By 964% Last Year - Simply Wall St
Zenvia Inc. (NASDAQ:ZENV) Q2 2024 Earnings Call Transcript - MSN
Zenvia CMO Marcelo Wakatsuki steps down, interim named By Investing.com - Investing.com South Africa
Zenvia Inc. Announces Leadership Change in Marketing - TipRanks
Zenvia CMO Marcelo Wakatsuki steps down, interim named - Investing.com UK
Zenvia establishes at-the-market equity programme in Brazil - Latin Lawyer
Zenvia Customer Cloud hits the market with AI to revolutionize Brand-CX - Martechcube
Zenvia Customer Cloud hits the market with AI to revolutionize Brand-Customer experiences - StockTitan
Zenvia Inc. (NASDAQ:ZENV) Short Interest Up 24.6% in September - MarketBeat
Zenvia Inc. (NASDAQ:ZENV) Short Interest Down 59.9% in September - MarketBeat
Affinity Asset Advisors LLC Invests $3.84 Million in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Canada
Is this affordable and accessible eyewear brand worth the hype? - Reviewed
Wedbush lifts Zentalis Pharmaceuticals Inc [ZNTL] price estimate. Who else is bullish? - The DBT News
Trading Day Review: Zevra Therapeutics Inc (ZVRA) Loses Momentum, Closing at 7.53 - The Dwinnex
Adversity is less terrifying than hope: Zentalis Pharmaceuticals Inc (ZNTL) - SETE News
You might want to take a look at Zevra Therapeutics Inc (ZVRA) now - SETE News
Potential Price Increase for Zentalis Pharmaceuticals Inc (ZNTL) After Recent Insider Activity - Knox Daily
Daily Market Movement: Zentalis Pharmaceuticals Inc (ZNTL) Sees a 11.41 Increase, Closing at 4.10 - The Dwinnex
Zenith UK appoints Sannah Rogers chief executive - CampaignLive
Zendaya's baby pics that show she's always been that girl - Hindustan Times
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com Canada
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor - Pharmaceutical Technology
Zevra Therapeutics Inc (ZVRA)’s stock decline to 7.78 per share - US Post News
Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies - Zacks Investment Research
Zeneara Reviews"HYPE-LEGIT" HAPPY Customer or Controversy? - openPR
IPO Radar: Applied Nutrition, Zenas BioPharma, BingEx - The Armchair Trader
Zenith Bank Rises Slightly after ‘Fund’ Amass Huge Shares - MarketForces Africa
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire
Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa
Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock By Investing.com - Investing.com South Africa
SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com
Understanding the Risks of Investing in Zevra Therapeutics Inc (ZVRA) - Knox Daily
Zentalis Pharmaceuticals Inc’s Banking’s 100-Day Moving Average at 6.58: Will the Stock Break Through? - The InvestChronicle
Zentalis clinical hold resolution came ‘no strings attached,’ says Oppenheimer - TipRanks
Zentalis Pharma gains as FDA lifts partial clinical hold on cancer drug studies - XM
Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies - MarketWatch
Zentalis Pharmaceuticals Advances with FDA Approval and Upcoming Data - TipRanks
Zenas Biopharma IPO raises $225 mln in US IPO market - Eyes On News
Zenas BioPharma shares rise nearly 8% in market debut - XM
Zenas BioPharma raises $225 mln in US IPO - Reuters
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering - GlobeNewswire
Zenvia Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion By Investing.com - Investing.com Canada
Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion - Investing.com India
Zenvia Inc. Complies with SEC’s September Filing - TipRanks
Zenvia Inc. Reports Mid-Year Financial Performance - TipRanks
Zenvia Inc. Soars with Robust Q2 2024 Earnings - TipRanks
Zenvia Reports Revenue and Profit Growth - TipRanks
Zenvia (NASDAQ:ZENV) Announces Quarterly Earnings Results - MarketBeat
Zenvia reports Q2 revenue BRL 231.2M vs. BRL 192.9M last year - TipRanks
ZENVIA Reports Q2 2024 and H1 2024 Results - StockTitan
1.59%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):